JP2009517009A5 - - Google Patents

Info

Publication number

JP2009517009A5

JP2009517009A5 JP2008541750A JP2008541750A JP2009517009A5 JP 2009517009 A5 JP2009517009 A5 JP 2009517009A5 JP 2008541750 A JP2008541750 A JP 2008541750A JP 2008541750 A JP2008541750 A JP 2008541750A JP 2009517009 A5 JP2009517009 A5 JP 2009517009A5

Authority

JP

Japan

Prior art keywords

polypeptide

seq

amino acid

group

sequence shown

Prior art date

2006-11-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims 154
• 229920001184 polypeptide Polymers 0.000 claims 146
• 102000004196 processed proteins & peptides Human genes 0.000 claims 146
• 235000001014 amino acid Nutrition 0.000 claims 45
• 125000003275 alpha amino acid group Chemical group 0.000 claims 29
• 230000035772 mutation Effects 0.000 claims 28
• 150000001413 amino acids Chemical class 0.000 claims 27
• 230000037430 deletion Effects 0.000 claims 18
• 238000012217 deletion Methods 0.000 claims 18
• 108020004707 nucleic acids Proteins 0.000 claims 11
• 102000039446 nucleic acids Human genes 0.000 claims 11
• 150000007523 nucleic acids Chemical class 0.000 claims 11
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
• 230000004988 N-glycosylation Effects 0.000 claims 8
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 8
• 239000004473 Threonine Substances 0.000 claims 8
• 208000007502 anemia Diseases 0.000 claims 8
• 208000035475 disorder Diseases 0.000 claims 7
• 239000012634 fragment Substances 0.000 claims 7
• 206010028980 Neoplasm Diseases 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 6
• 201000011510 cancer Diseases 0.000 claims 5
• 239000008194 pharmaceutical composition Substances 0.000 claims 5
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 4
• 210000004027 cell Anatomy 0.000 claims 4
• 229940079593 drug Drugs 0.000 claims 4
• 235000013922 glutamic acid Nutrition 0.000 claims 4
• 239000004220 glutamic acid Substances 0.000 claims 4
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 4
• 238000005534 hematocrit Methods 0.000 claims 4
• 208000024891 symptom Diseases 0.000 claims 4
• 102100031939 Erythropoietin Human genes 0.000 claims 3
• 210000003169 central nervous system Anatomy 0.000 claims 3
• 239000003795 chemical substances by application Substances 0.000 claims 3
• 208000020832 chronic kidney disease Diseases 0.000 claims 3
• 208000022831 chronic renal failure syndrome Diseases 0.000 claims 3
• 230000000295 complement effect Effects 0.000 claims 3
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 3
• 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 2
• 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 2
• 241000124008 Mammalia Species 0.000 claims 2
• 238000002512 chemotherapy Methods 0.000 claims 2
• 201000010099 disease Diseases 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 2
• 230000000694 effects Effects 0.000 claims 2
• 108020001507 fusion proteins Proteins 0.000 claims 2
• 102000037865 fusion proteins Human genes 0.000 claims 2
• 229940084986 human chorionic gonadotropin Drugs 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims 2
• 239000003381 stabilizer Substances 0.000 claims 2
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims 1
• 208000024827 Alzheimer disease Diseases 0.000 claims 1
• 208000030760 Anaemia of chronic disease Diseases 0.000 claims 1
• 208000024172 Cardiovascular disease Diseases 0.000 claims 1
• 102000003951 Erythropoietin Human genes 0.000 claims 1
• 108090000394 Erythropoietin Proteins 0.000 claims 1
• 206010020772 Hypertension Diseases 0.000 claims 1
• 108060003951 Immunoglobulin Proteins 0.000 claims 1
• 208000006136 Leigh Disease Diseases 0.000 claims 1
• 208000017507 Leigh syndrome Diseases 0.000 claims 1
• 206010024291 Leukaemias acute myeloid Diseases 0.000 claims 1
• 206010025323 Lymphomas Diseases 0.000 claims 1
• 208000034578 Multiple myelomas Diseases 0.000 claims 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
• 208000018737 Parkinson disease Diseases 0.000 claims 1
• 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
• 206010063837 Reperfusion injury Diseases 0.000 claims 1
• 208000036142 Viral infection Diseases 0.000 claims 1
• 230000036982 action potential Effects 0.000 claims 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
• 208000022400 anemia due to chronic disease Diseases 0.000 claims 1
• 239000008280 blood Substances 0.000 claims 1
• 210000004369 blood Anatomy 0.000 claims 1
• 210000000481 breast Anatomy 0.000 claims 1
• 201000008274 breast adenocarcinoma Diseases 0.000 claims 1
• 239000002299 complementary DNA Substances 0.000 claims 1
• 238000000502 dialysis Methods 0.000 claims 1
• 230000008482 dysregulation Effects 0.000 claims 1
• 229940105423 erythropoietin Drugs 0.000 claims 1
• 210000003527 eukaryotic cell Anatomy 0.000 claims 1
• 229940088597 hormone Drugs 0.000 claims 1
• 239000005556 hormone Substances 0.000 claims 1
• 229940127121 immunoconjugate Drugs 0.000 claims 1
• 102000018358 immunoglobulin Human genes 0.000 claims 1
• 230000000302 ischemic effect Effects 0.000 claims 1
• 208000032839 leukemia Diseases 0.000 claims 1
• 201000006417 multiple sclerosis Diseases 0.000 claims 1
• 210000003205 muscle Anatomy 0.000 claims 1
• 208000010125 myocardial infarction Diseases 0.000 claims 1
• 210000005036 nerve Anatomy 0.000 claims 1
• 208000020470 nervous system symptom Diseases 0.000 claims 1
• 239000002853 nucleic acid probe Substances 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 235000016709 nutrition Nutrition 0.000 claims 1
• 230000002669 organ and tissue protective effect Effects 0.000 claims 1
• 208000013371 ovarian adenocarcinoma Diseases 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 208000027232 peripheral nervous system disease Diseases 0.000 claims 1
• 210000001236 prokaryotic cell Anatomy 0.000 claims 1
• 210000002307 prostate Anatomy 0.000 claims 1
• 201000005825 prostate adenocarcinoma Diseases 0.000 claims 1
• 235000018102 proteins Nutrition 0.000 claims 1
• 102000004169 proteins and genes Human genes 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 238000001959 radiotherapy Methods 0.000 claims 1
• 208000015347 renal cell adenocarcinoma Diseases 0.000 claims 1
• 230000009385 viral infection Effects 0.000 claims 1
• HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 claims 1
• 229960002555 zidovudine Drugs 0.000 claims 1